Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
Saved in:
| Title: | Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies? |
|---|---|
| Authors: | Vo, Manh-Cuong1,2,3 (AUTHOR), Tran, Van-Dinh-Huan2 (AUTHOR), Nguyen, Van-Tan2 (AUTHOR), Ruzimurodov, Nodirjon4 (AUTHOR), Trung, Dung Tran5 (AUTHOR), Kim, Sang Ki2,3,6 (AUTHOR), Jung, Sung-Hoon2,7 (AUTHOR) shglory@hanmail.net, Lee, Je-Jung2,3,7 (AUTHOR) drjejung@chonnam.ac.kr |
| Source: | Journal of Hematology & Oncology. 10/27/2025, Vol. 18 Issue 1, p1-31. 31p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17568722 |
|---|---|
| DOI: | 10.1186/s13045-025-01744-9 |
